24 phenotypes from 2 alleles in 2 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Lzts1tm1Cro/Lzts1+ involves: 129 * C57BL/6J	increased carcinoma incidence	J:119989
	increased gastric adenocarcinoma incidence	J:119989
	increased hepatocellular carcinoma incidence	J:119989
	increased lung adenoma incidence	J:119989
	increased lymphoma incidence	J:119989
	increased mammary gland tumor incidence	J:119989
	increased stomach tumor incidence	J:119989
	increased tumor incidence	J:119989
Lzts1tm1Cro/Lzts1tm1Cro involves: 129 * C57BL/6J	abnormal cell cycle	J:119989
	abnormal fibroblast physiology	J:119989
	decreased fibroblast proliferation	J:119989
	increased carcinoma incidence	J:119989
	increased fibroblast apoptosis	J:119989
	increased gastric adenocarcinoma incidence	J:119989
	increased hepatocellular carcinoma incidence	J:119989
	increased lung adenocarcinoma incidence	J:119989
	increased lymphoma incidence	J:119989
	increased mammary gland tumor incidence	J:119989
	increased sarcoma incidence	J:119989
	increased stomach tumor incidence	J:119989
	increased tumor incidence	J:119989
Lzts1tm1Kso/Lzts1tm1Kso B6J.B6NTac-Lzts1tm1Kso	abnormal CNS synapse formation	J:226686
	abnormal CNS synaptic transmission	J:226686
	abnormal dendritic spine morphology	J:226686
	abnormal glutamate-mediated receptor currents	J:226686
	abnormal miniature excitatory postsynaptic currents	J:226686
	abnormal object recognition memory	J:226686
	abnormal spatial working memory	J:226686
	normal behavior/neurological phenotype	J:226686
	increased anxiety-related response	J:226686
	increased tumor incidence	J:226686
	prolonged excitatory postsynaptic current decay time	J:226686